PortfoliosLab logoPortfoliosLab logo
COO vs. LMAT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

COO vs. LMAT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, COO achieves a -19.29% return, which is significantly lower than LMAT's 13.92% return. Over the past 10 years, COO has underperformed LMAT with an annualized return of 4.74%, while LMAT has yielded a comparatively higher 21.54% annualized return.


COO

1D
1.12%
1M
5.76%
YTD
-19.29%
6M
-20.19%
1Y
-4.85%
3Y*
-10.79%
5Y*
-7.49%
10Y*
4.74%

LMAT

1D
3.77%
1M
-5.93%
YTD
13.92%
6M
10.03%
1Y
11.29%
3Y*
11.56%
5Y*
9.15%
10Y*
21.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

COO vs. LMAT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
COO
The Cooper Companies, Inc.
-19.29%-10.85%-2.83%14.47%-21.06%15.33%13.10%26.27%16.84%24.59%
LMAT
LeMaitre Vascular, Inc.
13.92%-10.95%63.63%24.60%-7.40%25.10%14.09%53.77%-25.13%26.58%

Correlation

The correlation between COO and LMAT is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.42

Correlation (3Y)
Calculated over the trailing 3-year period

0.38

Correlation (5Y)
Calculated over the trailing 5-year period

0.44

Correlation (10Y)
Calculated over the trailing 10-year period

0.35

Correlation (All Time)
Calculated using the full available price history since Oct 19, 2006

0.22

Over the past year, COO and LMAT have become more correlated (0.42) than their long-term average of 0.22, meaning their price movements have been converging.

Fundamentals

Market Cap

COO:

$12.90B

LMAT:

$2.12B

EPS

COO:

$1.19

LMAT:

$2.68

PE Ratio

COO:

55.43

LMAT:

34.36

PS Ratio

COO:

3.09

LMAT:

8.37

PB Ratio

COO:

1.57

LMAT:

5.21

Total Revenue (TTM)

COO:

$4.23B

LMAT:

$256.28M

Gross Profit (TTM)

COO:

$2.72B

LMAT:

$185.52M

EBITDA (TTM)

COO:

$669.70M

LMAT:

$90.48M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

COO vs. LMAT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COO
COO Risk / Return Rank: 3535
Overall Rank
COO Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
COO Sortino Ratio Rank: 3131
Sortino Ratio Rank
COO Omega Ratio Rank: 3131
Omega Ratio Rank
COO Calmar Ratio Rank: 3838
Calmar Ratio Rank
COO Martin Ratio Rank: 3636
Martin Ratio Rank

LMAT
LMAT Risk / Return Rank: 5353
Overall Rank
LMAT Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
LMAT Sortino Ratio Rank: 5252
Sortino Ratio Rank
LMAT Omega Ratio Rank: 5050
Omega Ratio Rank
LMAT Calmar Ratio Rank: 5454
Calmar Ratio Rank
LMAT Martin Ratio Rank: 5454
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COO vs. LMAT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


COOLMATDifference
Sharpe ratioReturn per unit of total volatility

-0.46

Sortino ratioReturn per unit of downside risk

-0.85

Omega ratioGain probability vs. loss probability

1.00

1.10

-0.10

Calmar ratioReturn relative to maximum drawdown

-0.16

0.47

-0.63

Martin ratioReturn relative to average drawdown

-0.37

0.97

-1.34

COO vs. LMAT - Sharpe Ratio Comparison

The current COO Sharpe Ratio is -0.16, which is lower than the LMAT Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of COO and LMAT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

COO vs. LMAT - Drawdown Comparison

The maximum COO drawdown since its inception was -98.88%, which is greater than LMAT's maximum drawdown of -75.69%. Use the drawdown chart below to compare losses from any high point for COO and LMAT.


Loading charts...

Drawdown Indicators


COOLMATDifference

Max Drawdown

Largest peak-to-trough decline

-98.88%

-75.69%

-23.19%

Max Drawdown (1Y)

Largest decline over 1 year

-30.05%

-24.33%

-5.72%

Max Drawdown (3Y)

Largest decline over 3 years

-46.97%

-33.32%

-13.65%

Max Drawdown (5Y)

Largest decline over 5 years

-48.24%

-37.93%

-10.31%

Max Drawdown (10Y)

Largest decline over 10 years

-48.24%

-47.65%

-0.59%

Current Drawdown

Current decline from peak

-41.94%

-21.48%

-20.46%

Average Drawdown

Average peak-to-trough decline

-40.56%

-18.96%

-21.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.07%

11.63%

+1.44%

Volatility

COO vs. LMAT - Volatility Comparison

The Cooper Companies, Inc. (COO) and LeMaitre Vascular, Inc. (LMAT) have volatilities of 10.82% and 10.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


COOLMATDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.82%

10.67%

+0.15%

Volatility (6M)

Calculated over the trailing 6-month period

18.34%

30.31%

-11.97%

Volatility (1Y)

Calculated over the trailing 1-year period

30.45%

37.36%

-6.91%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.19%

36.50%

-7.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.88%

41.51%

-13.63%

Dividends

COO vs. LMAT - Dividend Comparison

COO has not paid dividends to shareholders, while LMAT's dividend yield for the trailing twelve months is around 0.98%.


PositionTTM20252024202320222021202020192018201720162015
COO
The Cooper Companies, Inc.
0.00%0.00%0.00%0.02%0.02%0.01%0.02%0.02%0.02%0.03%0.03%0.04%
LMAT
LeMaitre Vascular, Inc.
0.98%1.23%0.69%0.99%1.09%0.88%0.94%0.95%1.18%0.69%0.71%0.93%

Financials

COO vs. LMAT - Financials Comparison

This section allows you to compare key financial metrics between The Cooper Companies, Inc. and LeMaitre Vascular, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00200.00M400.00M600.00M800.00M1.00B20222023202420252026
1.08B
66.55M
(COO) Total Revenue
(LMAT) Total Revenue
Values in USD except per share items

COO vs. LMAT - Profitability Comparison

The chart below illustrates the profitability comparison between The Cooper Companies, Inc. and LeMaitre Vascular, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%65.0%70.0%75.0%20222023202420252026
68.0%
72.7%
Portfolio components
COO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Cooper Companies, Inc. reported a gross profit of 735.40M and revenue of 1.08B. Therefore, the gross margin over that period was 68.0%.

LMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a gross profit of 48.40M and revenue of 66.55M. Therefore, the gross margin over that period was 72.7%.

COO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Cooper Companies, Inc. reported an operating income of -31.00M and revenue of 1.08B, resulting in an operating margin of -2.9%.

LMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported an operating income of 17.78M and revenue of 66.55M, resulting in an operating margin of 26.7%.

COO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Cooper Companies, Inc. reported a net income of -77.90M and revenue of 1.08B, resulting in a net margin of -7.2%.

LMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, LeMaitre Vascular, Inc. reported a net income of 15.68M and revenue of 66.55M, resulting in a net margin of 23.6%.


Frequently Asked Questions


COO and LMAT have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

COO has higher volatility (10.82%) compared to LMAT (10.67%). In terms of maximum drawdown, COO dropped -98.88% vs LMAT's -75.69%.

LMAT currently has the higher Sharpe Ratio (0.30 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for COO and LMAT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer